PURPOSE: Long-chain acyl-CoA dehydrogenase (LCAD) is a mitochondrial flavoenzyme thought to be one of the major enzymes responsible for the first step of long-chain fatty acid (LCFA) beta-oxidation. Surprisingly, recent studies have shown LCAD is hardly detectable in human tissues such as liver and heart. Skeletal muscle is the largest organ in the body in terms of mass, and accounts for the majority of LCFA oxidation, especially during exercise. The purpose of this study was to investigate the expression levels of LCAD in human skeletal muscle. METHODS: Muscle biopsies were obtained from the vastus lateralis of healthy athletic men and women, and examined for mRNA abundance, protein content, and enzyme activity of LCAD. We compared LCAD content with that of very-long chain acyl-CoA dehydrogenase (VLCAD) and medium chain acyl-CoA dehydrogenase (MCAD); two mitochondrial beta-oxidation enzymes that have overlapping chain-length specificity to that of LCAD. LCAD protein content and enzyme activity were also examined in enriched mitochondrial protein fractions. As controls, LCAD presence in skeletal muscle was compared to human heart, liver, and mouse skeletal muscle. RESULTS: The mRNA presence of LCAD in human skeletal muscle is significantly less than VLCAD and MCAD (0.08+/-0.01 vs 7.3+/-0.5 vs 2.4+/-0.2 respectively, P<or=0.0001). LCAD protein was undetectable in human muscle homogenates, and coordinately LCAD enzyme activity was undetectable in enriched mitochondrial samples. CONCLUSION: LCAD is minimally expressed in human skeletal muscle and likely does not play a significant role in LCFA oxidation.
PURPOSE:Long-chain acyl-CoA dehydrogenase (LCAD) is a mitochondrial flavoenzyme thought to be one of the major enzymes responsible for the first step of long-chain fatty acid (LCFA) beta-oxidation. Surprisingly, recent studies have shown LCAD is hardly detectable in human tissues such as liver and heart. Skeletal muscle is the largest organ in the body in terms of mass, and accounts for the majority of LCFA oxidation, especially during exercise. The purpose of this study was to investigate the expression levels of LCAD in human skeletal muscle. METHODS: Muscle biopsies were obtained from the vastus lateralis of healthy athletic men and women, and examined for mRNA abundance, protein content, and enzyme activity of LCAD. We compared LCAD content with that of very-long chain acyl-CoA dehydrogenase (VLCAD) and medium chain acyl-CoA dehydrogenase (MCAD); two mitochondrial beta-oxidation enzymes that have overlapping chain-length specificity to that of LCAD. LCAD protein content and enzyme activity were also examined in enriched mitochondrial protein fractions. As controls, LCAD presence in skeletal muscle was compared to human heart, liver, and mouse skeletal muscle. RESULTS: The mRNA presence of LCAD in human skeletal muscle is significantly less than VLCAD and MCAD (0.08+/-0.01 vs 7.3+/-0.5 vs 2.4+/-0.2 respectively, P<or=0.0001). LCAD protein was undetectable in human muscle homogenates, and coordinately LCAD enzyme activity was undetectable in enriched mitochondrial samples. CONCLUSION:LCAD is minimally expressed in human skeletal muscle and likely does not play a significant role in LCFA oxidation.
Authors: Anne L Friedlander; Kevin A Jacobs; Jill A Fattor; Michael A Horning; Todd A Hagobian; Timothy A Bauer; Eugene E Wolfel; George A Brooks Journal: Am J Physiol Endocrinol Metab Date: 2006-08-08 Impact factor: 4.310
Authors: Kevin A Jacobs; Ronald M Krauss; Jill A Fattor; Michael A Horning; Anne L Friedlander; Timothy A Bauer; Todd A Hagobian; Eugene E Wolfel; George A Brooks Journal: Am J Physiol Endocrinol Metab Date: 2006-05-09 Impact factor: 4.310
Authors: Luc J C van Loon; Michaela Thomason-Hughes; Dumitru Constantin-Teodosiu; René Koopman; Paul L Greenhaff; D Grahame Hardie; Hans A Keizer; Wim H M Saris; Anton J M Wagenmakers Journal: Am J Physiol Endocrinol Metab Date: 2005-05-10 Impact factor: 4.310
Authors: Regina Ensenauer; Miao He; Jan-Marie Willard; Eric S Goetzman; Thomas J Corydon; Brian B Vandahl; Al-Walid Mohsen; Grazia Isaya; Jerry Vockley Journal: J Biol Chem Date: 2005-07-14 Impact factor: 5.157
Authors: B S Andresen; S Olpin; B J Poorthuis; H R Scholte; C Vianey-Saban; R Wanders; L Ijlst; A Morris; M Pourfarzam; K Bartlett; E R Baumgartner; J B deKlerk; L D Schroeder; T J Corydon; H Lund; V Winter; P Bross; L Bolund; N Gregersen Journal: Am J Hum Genet Date: 1999-02 Impact factor: 11.025
Authors: M He; S L Rutledge; D R Kelly; C A Palmer; G Murdoch; N Majumder; R D Nicholls; Z Pei; P A Watkins; J Vockley Journal: Am J Hum Genet Date: 2007-06-04 Impact factor: 11.025
Authors: Malika Chegary; Heleen te Brinke; Jos P N Ruiter; Frits A Wijburg; Maria S K Stoll; Paul E Minkler; Michel van Weeghel; Horst Schulz; Charles L Hoppel; Ronald J A Wanders; Sander M Houten Journal: Biochim Biophys Acta Date: 2009-05-22
Authors: Megan E Beck; Yuxun Zhang; Sivakama S Bharathi; Beata Kosmider; Karim Bahmed; Mary K Dahmer; Lawrence M Nogee; Eric S Goetzman Journal: Mol Genet Metab Date: 2020-05-01 Impact factor: 4.797
Authors: Adam J Chicco; Catherine H Le; Erich Gnaiger; Hans C Dreyer; Jonathan B Muyskens; Angelo D'Alessandro; Travis Nemkov; Austin D Hocker; Jessica E Prenni; Lisa M Wolfe; Nathan M Sindt; Andrew T Lovering; Andrew W Subudhi; Robert C Roach Journal: J Biol Chem Date: 2018-03-14 Impact factor: 5.157
Authors: Eric S Goetzman; John F Alcorn; Sivakama S Bharathi; Radha Uppala; Kevin J McHugh; Beata Kosmider; Rimei Chen; Yi Y Zuo; Megan E Beck; Richard W McKinney; Helen Skilling; Kristen R Suhrie; Anuradha Karunanidhi; Renita Yeasted; Chikara Otsubo; Bryon Ellis; Yulia Y Tyurina; Valerian E Kagan; Rama K Mallampalli; Jerry Vockley Journal: J Biol Chem Date: 2014-03-03 Impact factor: 5.157
Authors: Kathryn C Jackson; Lindsay M Wohlers; Richard M Lovering; Rosemary A Schuh; Amy C Maher; Arend Bonen; Timothy R Koves; Olga Ilkayeva; David M Thomson; Deborah M Muoio; Espen E Spangenburg Journal: Am J Physiol Regul Integr Comp Physiol Date: 2012-11-28 Impact factor: 3.619
Authors: Yuxun Zhang; Sivakama S Bharathi; Matthew J Rardin; Radha Uppala; Eric Verdin; Bradford W Gibson; Eric S Goetzman Journal: PLoS One Date: 2015-03-26 Impact factor: 3.240